[Cervix cancer].
Cervix cancers declined in most developed countries in recent years, but remain, the third worldwide leading cause of cancer death in women. A precise staging, based on clinical exam, an abdominal and pelvic MRI, a possible PET-CT and a possible lymph node sampling is necessary to adapt the best therapeutic strategy. In France, the treatments of tumors of less than 4 cm without nodal involvement are often based on radiotherapy followed by surgery and, whereas tumors larger than 4 cm and involved nodes are treated with concurrent chemoradiotherapy. Based on an illustrated clinical case, indications, delineation, dosimetry and complications expected with radiotherapy are demonstrated.
Service de radiothérapie, centre régional universitaire de cancérologie Henry-S.-Kaplan CHU de Tours, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37000 Tours, France.
Y
Y
Pointreau
A
A
Ruffier Loubière
F
F
Denis
I
I
Barillot
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002584:Cervix Uteri / Q000033:anatomy & histology / Q000473:pathology; D003131:Combined Modality Therapy / Q000379:methods; D019049:Developed Countries / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D015994:Incidence; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods; D011859:Radiography; D011879:Radiotherapy Dosage; D020266:Radiotherapy, Conformal / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000473:pathology / Q000532:radiotherapy*
D000970:Antineoplastic Agents